Clinical trial
Safety Profiles of Percutaneous Liver Biopsy in Hemodialysis Patients With Chronic Hepatitis C Pre-treated With 1-Deamino-8- D-Arginine Vasopressin
NCT00635310 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety Profiles of Percutaneous Liver Biopsy in Hemodialysis Patients With Chronic Hepatitis C Pre-treated With 1-Deamino-8- D-Arginine Vasopressin
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2005
- Completion date
- July 31, 2013
- Enrollment
- 3,520 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
biopsy, chronic hepatitis b, chronic hepatitis c, hemodialysis